https://www.globenewswire.com/news-release/2017/08/08/1081422/29489/en/Hemispherx-Biopharma-Announces-Collaboration-with-Millions-Missing-Canada-to-Bring-Medication-to-Canadians-for-Myalgic-Encephalomyelitis-Chronic-Fatigue-Syndrome.html
Hemispherx Biopharma Announces Collaboration with Millions
Advocacy Organization to Work with Health Canada with the Goal to Gain Approval...
hemispherx biopharmaannouncescollaborationmillions
https://www.globenewswire.com/news-release/2017/08/11/1083780/29489/en/Hemispherx-Biopharma-to-Host-Conference-Call-to-Discuss-Second-Quarter-Financial-Results-on-Tuesday-August-15-2017.html
Hemispherx Biopharma to Host Conference Call to Discuss
Financials for Second Quarter Ended June 30, 2017 will be released on August 14, 2017...
hemispherx biopharmato hostconference calldiscuss
https://www.globenewswire.com/news-release/2017/08/15/1084773/29489/en/Hemispherx-Biopharma-Announces-Corporate-Progress-and-Financial-Results-for-the-Six-Months-Ended-June-30-2017.html
Hemispherx Biopharma Announces Corporate Progress and
hemispherx biopharmaannouncescorporateprogress
https://www.biospace.com/hemispherx-biopharma-announces-investors-conference-call-143998
Hemispherx Biopharma Announces Investors Conference Call - BioSpace
hemispherx biopharmaconference callannouncesinvestors
https://www.globenewswire.com/news-release/2017/05/15/985144/29489/en/Hemispherx-Biopharma-Announces-Financial-Results-for-the-Three-Months-Ended-March-31-2017.html
Hemispherx Biopharma Announces Financial Results for the
The company has generated revenues from the lots of newly manufactured Ampligen...
hemispherx biopharmafinancial resultsannounces
https://www.biospace.com/hemispherx-biopharma-announces-third-quarter-2006-results-and-strategic-update
Hemispherx Biopharma Announces Third Quarter 2006 Results And Strategic Update - BioSpace
hemispherx biopharmathird quarter2006 resultsannounces
https://www.biospace.com/b-hemispherx-biopharma-europe-n-v-s-a-b-receives-orphan-medicine-designation-by-the-hemispherx-biopharma-for-ampligen-to-treat-patients-with-ebol
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation By The Hemispherx...